Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene

Blood

Volumn 128, Issue 8, 2016, Pages 1101-1111

  Schmidt, Janine ^a   Gong, Shunyou ^b   Marafioti, Teresa ^c   Mankel, Barbara ^a   Gonzalez Farre, Blanca ^d   Balagué, Olga ^d   Mozos, Ana ^e   Cabeçadas, José ^f   Van Der Walt, Jon ^g   Hoehn, Daniela ^h   Rosenwald, Andreas ⁱ   Ott, German ^j   Dojcinov, Stefan ^k   Egan, Caoimhe ^b   Nadeu, Ferran ^d   Ramis Zaldívar, Joan Enric ^d   Clot, Guillem ^d   Bárcena, Carmen ^l   Pérez Alonso, Vanesa ^l   Endris, Volker ^m   Penzel, Roland ^m   Lome Maldonado, Carmen ⁿ   Bonzheim, Irina ^a   Fend, Falko ^a   Campo, Elias ^d   Jaffe, Elaine S ^b   Salaverria, Itziar ^d   Quintanilla Martinez, Leticia ^a   more..

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

^d HOSPITAL CLÍNIC   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^g GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^h NewYork Presbyterian Hospital   (United States)

ⁱ UNIVERSITY OF WÜRZBURG   (Germany)

^j ROBERT BOSCH HOSPITAL   (Germany)

^k UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^l HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^m UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

ⁿ INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HERPESVIRUS ENTRY MEDIATOR; PARAPROTEIN; TNFRSF14 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; FOLLICULAR LYMPHOMA; GENE DELETION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; MOLECULAR PATHOLOGY; PEDIATRIC TYPE FOLLICULAR LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; YOUNG ADULT; CELL CLONE; CHROMOSOME 14; CHROMOSOME 18; CHROMOSOME ANALYSIS; DNA MUTATIONAL ANALYSIS; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MUTATION; PATHOLOGY; PSEUDOLYMPHOMA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; CLONE CELLS; CYTOGENETIC ANALYSIS; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; LYMPHOMA, FOLLICULAR; MALE; MUTATION; PSEUDOLYMPHOMA; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 84984675232     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-03-703819     Document Type: Article

References (41)

1. Harris NL, Swerdlow SH, Jaffe E. Follicular lymphoma. In: Jaffe E, Harris NL, Stein H, Vardiman JW, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2008:220-226.
2. Oschlies I, Salaverria I, Mahn F, et al. Pediatric follicular lymphoma-a clinicopathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma-Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials. Haematologica. 2010;95(2):253-259.
3. Winberg CD, Nathwani BN, Bearman RM, Rappaport H. Follicular (nodular) lymphoma during the first two decades of life: a clinicopathologic study of 12 patients. Cancer. 1981;48(10):2223-2235.
4. Frizzera G, Murphy SB. Follicular (nodular) lymphoma in childhood: a rare clinicalpathological entity. Report of eight cases from four cancer centers. Cancer. 1979;44(6):2218-2235.
5. Liu Q, Salaverria I, Pittaluga S, et al. Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol. 2013; 37(3):333-343.
6. Louissaint A Jr, Ackerman AM, Dias-Santagata D, et al. Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. Blood. 2012; 120(12):2395-2404.
7. Lorsbach RB, Shay-Seymore D, Moore J, et al. Clinicopathologic analysis of follicular lymphoma occurring in children. Blood. 2002;99(6): 1959-1964.
8. Attarbaschi A, Beishuizen A, Mann G, et al; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the international Berlin-Frankfurt-Münster (i-BFM) Study Group. Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "Watch and wait" strategy after complete resection. Ann Hematol. 2013; 92(11):1537-1541.
9. Martin-Guerrero I, Salaverria I, Burkhardt B, et al. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas. Haematologica. 2013;98(8): 1237-1241.
10. Launay E, Pangault C, Bertrand P, et al. High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis. Leukemia. 2012;26(3):559-562.
11. Cheung KJ, Johnson NA, Affleck JG, et al. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res. 2010;70(22):9166-9174.
12. Schmidt J, Salaverria I, Haake A, et al. Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma. Leukemia. 2014;28(5): 1103-1112.
13. Kridel R, Sehn LH, Gascoyne RD. Pathogenesis of follicular lymphoma. J Clin Invest. 2012; 122(10):3424-3431.
14. Green MR, Kihira S, Liu CL, et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proc Natl Acad Sci USA. 2015;112(10): E1116-E1125.
15. Loeffler M, Kreuz M, Haake A, et al; HaematoSys-Project. Genomic and epigenomic co-evolution in follicular lymphomas. Leukemia. 2015;29(2): 456-463.
16. Okosun J, Bödör C, Wang J, et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet. 2014;46(2):176-181.
17. Pasqualucci L, Khiabanian H, Fangazio M, et al. Genetics of follicular lymphoma transformation. Cell Reports. 2014;6(1):130-140.
18. Li H, Kaminski MS, Li Y, et al. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. Blood. 2014; 123(10):1487-1498.
19. Okosun J, Wolfson RL, Wang J, et al. Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. Nat Genet. 2016;48(2): 183-188.
20. Quintanilla-Martinez L, Sander B, Chan JK, et al. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia. Virchows Arch. 2016; 468(2):141-157.
21. Leich E, Hoster E, Wartenberg M, et al; German Low Grade Lymphoma Study Group (GLSG). Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus. Leukemia. 2016;30(4):854-860.
22. Swerdlow SH, Campo E, Harris NL, et al. World Health Organization Classification of Tumours. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Vol. 4. Lyon, France: IARC Press; 2008.
23. Adam P, Baumann R, Schmidt J, et al. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas. Hum Pathol. 2013;44(9):1817-1826.
24. van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317.
25. Salaverria I, Philipp C, Oschlies I, et al; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe; German High-Grade Lymphoma Study Group; Berlin-Frankfurt-Münster-NHL Trial Group. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood. 2011;118(1):139-147.
26. Karube K, Guo Y, Suzumiya J, et al. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood. 2007;109(7): 3076-3079.
27. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390.
28. Green MR, Gentles AJ, Nair RV, et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood. 2013;121(9):1604-1611.
29. Steinberg MW, Cheung TC, Ware CF. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunol Rev. 2011;244(1):169-187.
30. Compaan DM, Gonzalez LC, Tom I, Loyet KM, Eaton D, Hymowitz SG. Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J Biol Chem. 2005;280(47): 39553-39561.
31. Kojima R, Kajikawa M, Shiroishi M, Kuroki K, Maenaka K. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT. J Mol Biol. 2011;413(4):762-772.
32. Rooney IA, Butrovich KD, Glass AA, et al. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem. 2000;275(19):14307-14315.
33. Cai G, Freeman GJ. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev. 2009;229(1): 244-258.
34. M'Hidi H, Thibult ML, Chetaille B, et al. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Am J Clin Pathol. 2009;132(4):589-596.
35. Fujita T, Igarashi J, Okawa ER, et al. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas. J Natl Cancer Inst. 2008; 100(13):940-949.
36. Krona C, Ejeskär K, Abel F, et al. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene. 2003;22(15):2343-2351.
37. Ortega-Molina A, Boss IW, Canela A, et al. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat Med. 2015;21(10): 1199-1208.
38. Zhang J, Dominguez-Sola D, Hussein S, et al. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat Med. 2015;21(10): 1190-1198.
39. Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem. 2012;81:65-95.
40. Bödör C, Grossmann V, Popov N, et al. EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood. 2013; 122(18):3165-3168.
41. Leich E, Salaverria I, Bea S, et al. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood. 2009;114(4):826-834.